Skip to content

Follistatin

A naturally occurring protein that inhibits myostatin (the muscle growth limiter), studied for dramatic muscle growth potential.

EmergingLimited Data

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

What is Follistatin?

Follistatin is a naturally occurring glycoprotein that binds and neutralizes myostatin, activin, and other TGF-beta superfamily members. Myostatin is the body's primary brake on muscle growth. By inhibiting myostatin, follistatin allows enhanced muscle development. Gene therapy approaches using follistatin have shown dramatic results in animal models and early human trials for muscular dystrophy.

Why People Talk About It

Myostatin inhibition for muscle growth

Emerging

Potential muscular dystrophy treatment

Emerging

Body composition improvement

Preliminary

How It Works

Your body has a built-in limit on how much muscle you can build, controlled by a protein called myostatin. Follistatin acts as myostatin's natural off-switch, removing the brake and allowing greater muscle growth.

Common Questions

Safety Information

Important Safety Notes

Common Side Effects

Limited human data for exogenous administrationPotential reproductive effects (activin is involved in FSH regulation)

Cautions

  • Not FDA-approved
  • May affect reproductive hormones
  • Protein is rapidly cleared, limiting practical use of injected forms
  • Gene therapy approaches carry their own risks

What We Don't Know

Long-term effects of chronic myostatin inhibition in humans are unknown. Reproductive and cardiac effects need more study.

Published Research

32 studies

Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis

Meta-AnalysisPMID: 41521726

Effectiveness of resistance training on body composition, muscle strength, and biomarker in sarcopenic older adults: A meta-analysis of randomized controlled trials

Meta-AnalysisPMID: 39191151

The Association between Serum Follistatin-like Proteins and Cardiovascular Diseases: A Systematic Review and Meta-analysis

Meta-AnalysisPMID: 39034719

The effects of resistance training on myostatin and follistatin in adults: A systematic review and meta-analysis

Meta-AnalysisPMID: 37328021

Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Meta-AnalysisPMID: 36351545

Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis

Meta-AnalysisPMID: 33849530

Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis

Meta-AnalysisPMID: 33740002

Effects of liraglutide treatment for 35-days on total and regional fat free, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study

Randomized Controlled TrialPMID: 41571048

Adipo-Myokine Modulation in Obesity: Integrative Effects of Spinach Thylakoids and Functional Training in Men with Obesity: A Randomized Controlled Clinical Trial

Randomized Controlled TrialPMID: 41683333

The Effect of Exercise on Spexin and Follistatin in Elderly Individuals

Randomized Controlled TrialPMID: 39895162

Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia

Randomized Controlled TrialPMID: 40011687

Effects of Resistance Training on Muscular Adaptations and Inflammatory Markers in Overweight and Obese Men

Randomized Controlled TrialPMID: 39809255

Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: a randomized controlled trial

Randomized Controlled TrialPMID: 39558011

Supplementing With Which Form of Creatine (Hydrochloride or Monohydrate) Alongside Resistance Training Can Have More Impacts on Anabolic/Catabolic Hormones, Strength and Body Composition?

Randomized Controlled TrialPMID: 39545789

Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Randomized Controlled TrialPMID: 39683431

Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males

Randomized Controlled TrialPMID: 39275173

Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments

Randomized Controlled TrialPMID: 36843579

The impact of mild hypoxia exposure on myokine secretion in human obesity

Randomized Controlled TrialPMID: 36997723

Effects of Icelandic yogurt consumption and resistance training in healthy untrained older males

Randomized Controlled TrialPMID: 34121642

Spirulina supplementation during gradual weight loss in competitive wrestlers

Randomized Controlled TrialPMID: 33715648

Intensity Dependent Effects of Interval Resistance Training on Myokines and Cardiovascular Risk Factors in Males With Obesity

Randomized Controlled TrialPMID: 35757424

Effects of Soy Milk in Conjunction With Resistance Training on Physical Performance and Skeletal Muscle Regulatory Markers in Older Men

Randomized Controlled TrialPMID: 35332795

Effects of 16 Weeks of Resistance Training on Muscle Quality and Muscle Growth Factors in Older Adult Women with Sarcopenia: A Randomized Controlled Trial

Randomized Controlled TrialPMID: 34201810

Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS

Randomized Controlled TrialPMID: 32968804

Effects of branched-chain amino acid supplementation and resistance training in postmenopausal women

Randomized Controlled TrialPMID: 33279662

The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients

Randomized Controlled TrialPMID: 32470863

Comparable endocrine and neuromuscular adaptations to variable vs. constant gravity-dependent resistance training among young women

Randomized Controlled TrialPMID: 32539753

The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men

Randomized Controlled TrialPMID: 32035222

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial

Randomized Controlled TrialPMID: 31672146

Effects of upper-body, lower-body, or combined resistance training on the ratio of follistatin and myostatin in middle-aged men

Randomized Controlled TrialPMID: 31240397

Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin

PreclinicalPMID: 19435857

Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice

PreclinicalPMID: 19108572

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician

Related Peptides

Quick Facts

Class
Activin-Binding Protein
Evidence
Emerging
Safety
Limited Data
Updated
Mar 2026
Citations
32PubMed

Also known as

FSTFollistatin-344Follistatin-315

Tags

Muscle GrowthMyostatin InhibitorPerformance

Related Goals

Evidence Score

Overall Confidence45%

Clinical Trials

View Clinical Trials

Links to ClinicalTrials.gov for reference. Listing does not imply endorsement.

Clinician Guided

Interested in this peptide? A Noho clinician can help determine if it's right for you.

Talk to a Clinician